Home » Publications »
Goulden S, Heffernan K, Nikitas FS, Shukla U, Knott CS, Hunger M, Pahwa A, Schade R. Comparison of survival outcomes between dostarlimab and comparator treatments (tx) in patients (pts) with advanced/recurrent (A/R) endometrial cancer (EC) in England: Matching-adjusted indirect comparisons (MAICs). ASCO 2022; 2022 June 3-7.